References
- Gabizon A., Goren D., Fuks Z., Barenholz Y., Dagen A., Meshorer A. Enhancement of adriamycin delivery to metastatic cells with increased tumoricidal effect using liposomes as drug carriers. Cancer Res (1983); 43: 4730–4735
- Hisaoka M., Tsukada K., Morioka T. Studies on liposome‐encapsulated carboquone on distribution and clearance in animals. J. Pharmacobio. Dyn (1982); 5: 18–26
- Ichino T., Yotsuyanagi T., Mizuno I., Akamo Y., Yamamoto T., Saito T., Kurahasi S., Tanimoto N., Yura J. Antitumor effect of liposome‐entrapped adriamycin administered via the portal vein. Jpn. J. Cancer Res (1990); 81: 1052–1056
- Klibanov A. L., Maruyama K., Torchilin V. P., Huang L. Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes. FEBS Lett (1990); 268: 235–237
- Liu D., Mori A., Huang L. Role of liposome size and RES blockade in controlling biodistribution and tumor uptake of GM1‐containing liposomes. Biochim. Biophys. Acta (1992); 1104: 95–101
- Mori A., Klibanov A. L., Torchilin V. P., Huang L. Influence of the steric barrier activity of amphipathic poly (ethyleneglycol) and ganglioside GM1 on the circulation time of liposomes and on the target binding of immunoliposomes in vivo. FEBS lett (1991); 284(2)263–266
- Negishi T., Takahira H. Incorporation of adriamycin into cell nuclei and interaction between adriamycin and DNA. YAKUGAKU ZASSHI (1973); 93: 1498–1508
- Oku N., Namba Y., Okada S. Tumor accumulation of novel RES‐avoiding liposomes. Biochim. Biophys. Acta (1992); 1126: 255–260
- Pirson P., Steigar R., Trouet A. The disposition of free and liposomally encapsulated antimalarial primaquine in mice. Biochem. Pharmacol (1982); 31: 3501–3507
- Storm G., Bloois L. V., Steerenberg P. A., Etten E. V., Groot G. D., Crommelin D. J. A. Liposome encapsulation of doxorubicin: pharmaceutical and therapeutic aspects. J. of Control. Release (1989); 9: 215–229